Tyler Hayes

Tyler joined Thuja as a Principal in early 2023. He worked previously as a consultant at Boston Consulting Group and intern at Novartis Venture Fund. Tyler completed his medical training at Harvard, where he also conducted research on improving blood stem cell engraftment after transplantation. Prior to Harvard, Tyler led a research project at King’s College London which elucidated the role of common genetic mutations in oral cancer. He was a 2012 Fulbright Scholar to EPFL, Switzerland. Tyler holds an MD from Harvard Medical School, an MRes in Translational Cancer Medicine from King’s College London, an MBA from London Business School, and a BSc in Cell & Molecular Biology from Duke University.

Mobile: +31 6 18899608
Email | View my profile